查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1356799

口咽癌診斷與治療藥物市場報告：至2030年的趨勢、預測與競爭分析

Oropharyngeal Cancer Diagnosis and Therapeutics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

口咽癌診療藥物的發展趨勢及預測

預計到2030年，全球口咽癌診斷和治療市場將達33億美元，2024年至2030年年複合成長率為9.2%。該市場的主要促進因素是口咽癌罹患率上升、菸酒消費量高以及人類乳突病毒（HPV）感染率上升。全球口咽癌診斷和治療藥物市場前景廣闊，醫院和門診手術中心市場存在商機。

口咽癌診斷與治療藥物市場洞察

Lucintel 預測 ，CT 掃描將在預測期內達到最高成長。

醫院繼續是最大的區隔，因為是診斷和治療口咽癌的主要設施，並擁有提供這些關鍵服務所需的必要基礎設施和專業知識。

由於口咽癌患者數量不斷增加以及人們對口咽癌的認知不斷增強，預計亞太地區在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1.細分市場中最有前途和高成長的機會為何？
  • Q.2.未來哪個細分市場成長較快？理由為何？
  • Q.3.哪些地區未來會出現更快的成長？理由為何？
  • Q.4.影響市場動態的主要要素有哪些？市場的主要挑戰和商業風險是什麼？
  • Q.5.這個市場的商業風險和競爭威脅為何？
  • Q.6.這個市場有哪些新趨勢？理由為何？
  • Q.7.市場客戶需求有何改變？
  • Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10.該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
  • Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球口咽癌診斷與治療市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球口咽癌診斷及治療市場趨勢（2018-2023）及預測（2024-2030）
  • 全球口咽癌診斷和治療市場（依類型）
    • 內視鏡
    • 切片檢查
    • 影像
    • 核磁共振掃描
    • CT掃描
    • 寵物CT掃描
  • 按治療分類的全球口咽癌診斷與治療市場
    • 外科手術
    • 化療
    • 放射治療
    • 標靶治療
    • 其他
  • 全球口咽癌診斷與治療市場（依最終用途）
    • 醫院
    • 門診手術中心
    • 其他

第4章 2018-2030年市場趨勢及預測分析（依地區）

  • 全球口咽癌診斷與治療市場（依地區）
  • 北美口咽癌診斷與治療市場
  • 歐洲口咽癌診斷與治療市場
  • 亞太地區口咽癌診斷與治療市場
  • 其他地區口咽癌診療市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球口咽癌診斷與治療市場成長機會（依類型）
    • 全球口咽癌診斷與治療市場成長機會（依治療）
    • 全球口咽癌診斷和治療市場成長機會（依最終用途）
    • 全球口咽癌診斷與治療市場成長機會（依地區）
  • 全球口咽癌診斷與治療市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球口咽癌診斷和治療市場的能力
    • 全球口咽癌診斷和治療市場的收購和合資
    • 認證和許可

第7章 主要企業概況

  • Ab Sciences
  • Advaxis
  • AstraZeneca
  • Bayer
  • Boston Biomedical
  • Bristol-Myers Squibb
  • GE Healthcare
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Merck
簡介目錄

Oropharyngeal Cancer Diagnosis and Therapeutics Trends and Forecast

The future of the global oropharyngeal cancer diagnosis and therapeutics market looks promising with opportunities in the hospital and ambulatory surgery center markets. The global oropharyngeal cancer diagnosis and therapeutics market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 9.2% from 2024 to 2030. The major drivers for this market are rising incidence of oropharyngeal cancer, high tobacco and alcohol consumption ,and rise in human papillomavirus (hpv) infections.

A more than 150-page report is developed to help in your business decisions.

Oropharyngeal Cancer Diagnosis and Therapeutics by Segment

The study includes a forecast for the global oropharyngeal cancer diagnosis and therapeutics by type, treatment, end use, and region.

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Endoscopy
  • Biopsy
  • Imaging
  • MRI Scan
  • CT Scan
  • Pet-CT Scan

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment [Shipment Analysis by Value from 2018 to 2030]:

  • Surgery
  • Chemotherapy
  • Radiation Therapy
  • Targeted Therapy
  • Others

Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Ambulatory Surgery Centers
  • Others

Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Oropharyngeal Cancer Diagnosis and Therapeutics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies oropharyngeal cancer diagnosis and therapeutics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oropharyngeal cancer diagnosis and therapeutics companies profiled in this report include-

  • Ab Sciences
  • Advaxis
  • Astrazeneca
  • Bayer
  • Boston Biomedical
  • Bristol-Myers Squibb
  • Ge Healthcare
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Merck

Oropharyngeal Cancer Diagnosis and Therapeutics Market Insights

Lucintel forecasts that CT scan is expected to witness highest growth over the forecast period.

Hospitals will remain the largest segment as it serves as the primary facilities for diagnosing and treating oropharyngeal cancer and possess the essential infrastructure and specialized expertise required to deliver these crucial services.

APAC is expected to witness highest growth over the forecast period due to rising cases of oropharyngeal cancer and increasing awareness towards oropharyngeal.

Features of the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market

Market Size Estimates: Oropharyngeal cancer diagnosis and therapeutics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Oropharyngeal cancer diagnosis and therapeutics market size by type, treatment, end use, and region. in terms of value ($B).

Regional Analysis: Oropharyngeal cancer diagnosis and therapeutics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, treatments , end uses, and region.s for the oropharyngeal cancer diagnosis and therapeutics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oropharyngeal cancer diagnosis and therapeutics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the oropharyngeal cancer diagnosis and therapeutics market size?

Answer: The global oropharyngeal cancer diagnosis and therapeutics market is expected to reach an estimated $3.3 billion by 2030.

Q.2. What is the growth forecast for oropharyngeal cancer diagnosis and therapeutics market?

Answer: The global oropharyngeal cancer diagnosis and therapeutics market is expected to grow with a CAGR of 9.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the oropharyngeal cancer diagnosis and therapeutics market?

Answer: The major drivers for this market are rising incidence of oropharyngeal cancer, high tobacco and alcohol consumption, and rise in human papillomavirus (HPV) infections.

Q.4. What are the major segments for oropharyngeal cancer diagnosis and therapeutics market?

Answer: The future of the oropharyngeal cancer diagnosis and therapeutics market looks promising with opportunities in the hospital and ambulatory surgery center markets.

Q.5. Who are the key oropharyngeal cancer diagnosis and therapeutics market companies?

Answer: Some of the key oropharyngeal cancer diagnosis and therapeutics companies are as follows:

  • Ab Sciences
  • Advaxis
  • AstraZeneca
  • Bayer
  • Boston Biomedical
  • Bristol-Myers Squibb
  • GE Healthcare
  • Immunovaccine
  • Inovio Pharmaceuticals
  • Merck

Q.6. Which oropharyngeal cancer diagnosis and therapeutics market segment will be the largest in future?

Answer: Lucintel forecasts that CT scan is expected to witness highest growth over the forecast period.

Q.7. In oropharyngeal cancer diagnosis and therapeutics market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to rising cases of oropharyngeal cancer and increasing awareness towards oropharyngeal.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the oropharyngeal cancer diagnosis and therapeutics market by type (endoscopy, biopsy, imaging, MRI scan, CT scan, and pet-CT scan), treatment (surgery, chemotherapy, radiation therapy, targeted therapy, and others), end use (hospitals, ambulatory surgery centers, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type
    • 3.3.1: Endoscopy
    • 3.3.2: Biopsy
    • 3.3.3: Imaging
    • 3.3.4: MRI Scan
    • 3.3.5: CT Scan
    • 3.3.6: Pet-CT Scan
  • 3.4: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment
    • 3.4.1: Surgery
    • 3.4.2: Chemotherapy
    • 3.4.3: Radiation Therapy
    • 3.4.4: Targeted Therapy
    • 3.4.5: Others
  • 3.5: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Ambulatory Surgery Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region
  • 4.2: North American Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.2.2: North American Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.3: European Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.3.1: European Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
    • 4.3.2: European Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.4: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.4.1: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
    • 4.4.2: APAC Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others
  • 4.5: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 4.5.1: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type: Endoscopy, Biopsy, Imaging, MRI Scan, CT Scan, and Pet-CT Scan
    • 4.5.2: ROW Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use: Hospitals, Ambulatory Surgery Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Type
    • 6.1.2: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Treatment
    • 6.1.3: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by End Use
    • 6.1.4: Growth Opportunities for the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market by Region
  • 6.2: Emerging Trends in the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oropharyngeal Cancer Diagnosis and Therapeutics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Ab Sciences
  • 7.2: Advaxis
  • 7.3: AstraZeneca
  • 7.4: Bayer
  • 7.5: Boston Biomedical
  • 7.6: Bristol-Myers Squibb
  • 7.7: GE Healthcare
  • 7.8: Immunovaccine
  • 7.9: Inovio Pharmaceuticals
  • 7.10: Merck